Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SHR-2002 by Jiangsu Hengrui Medicine for Solid Tumor: Likelihood of Approval
SHR-2002 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Solid Tumor. According to GlobalData,...
Data Insights
SHR-2002 by Jiangsu Hengrui Medicine for Advanced Malignancy: Likelihood of Approval
SHR-2002 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Advanced Malignancy. According to GlobalData,...